Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 105 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 7045510

    Methods for prevention and treatment of mastitis

    The United States of America, as represented by the Secretary of Agriculture · Granted May 16, 2006 · Expires May 11, 2026

    expired
  2. US 7045136

    Methods of immunization using recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences

    The United States of America, as represented by the Department of Health and Human Services · Granted May 16, 2006 · Expires May 11, 2026

    expired
  3. US 7045675

    Genes for Niemann-Pick type C disease

    The United States of America, as represented by the Department of Health and Human Services · Granted May 16, 2006 · Expires May 11, 2026

    expired
  4. US 7041503

    Modified myelin basic protein molecules

    The United States of America, as represented by the Department of Health and Human Services · Granted May 9, 2006 · Expires May 4, 2026

    expired
  5. US 7041498

    Method for modulating processes mediated by farnesoid activated receptors

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA · Granted May 9, 2006 · Expires May 4, 2026

    expired
  6. US 7041296

    Methods of treating inflammatory bowel disease using cholera toxin B subunit

    The United States of America, as represented by the Department of Health and Human Services · Granted May 9, 2006 · Expires May 4, 2026

    expired
  7. US 7037680

    Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy

    The United States of America as represented by the Secretary of the Army · Granted May 2, 2006 · Expires Apr 27, 2026

    expired
  8. US 7037499

    Adjuvant for transcutaneous immunization

    The United States of America as represented by the Secretary of the Army · Granted May 2, 2006 · Expires Apr 27, 2026

    expired
  9. US 7033608

    “Burst-free” sustained release poly-(lactide/glycolide) microspheres

    The United States of America as represented by the Secretary of the Army · Granted Apr 25, 2006 · Expires Apr 20, 2026

    expired
  10. US 7029899

    Selective toxicity of amino-terminal modified rnase a superfamily polypeptides

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 18, 2006 · Expires Apr 13, 2026

    expired
  11. US 7029685

    Plasmodium falciparum AMA-1 protein and uses thereof

    The United States of America as represented by the Secretary of the Army · Granted Apr 18, 2006 · Expires Apr 13, 2026

    expired
  12. US 7026350

    Water-soluble drugs and methods for their production

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 11, 2006 · Expires Apr 6, 2026

    expired
  13. US 7025961

    Anti-plasmodium composition and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 11, 2006 · Expires Apr 6, 2026

    expired
  14. US 7026291

    Epithelial cell specific growth factor, keratinocyte growth factor (KGF)

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 11, 2006 · Expires Apr 6, 2026

    expired
  15. US 7025963

    Vaccine against Gram-negative bacterial infections

    The United States of America as represented by the Secretary of the Army · Granted Apr 11, 2006 · Expires Apr 6, 2026

    expired
  16. US 7022315

    Administration of a thiol-based chemoprotectant compound

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS · Granted Apr 4, 2006 · Expires Mar 30, 2026

    expired
  17. US 7018636

    Vaccine against Gram-negative bacterial infections

    The United States of America as represented by the Secretary of the Army · Granted Mar 28, 2006 · Expires Mar 23, 2026

    expired
  18. US 7015212

    Thiazepine inhibitors of HIV-1 integrase

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 21, 2006 · Expires Mar 16, 2026

    expired
  19. US 7015312

    Antibodies to the protein product encoded by ORF3 of the TRP-1 gene and compositions and kits thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 21, 2006 · Expires Mar 16, 2026

    expired
  20. US 7015024

    Compositions containing recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 21, 2006 · Expires Mar 16, 2026

    expired
  21. US 7009050

    5-Substituted pyrimidine derivatives of conformationally locked nucleoside analogues

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 7, 2006 · Expires Mar 2, 2026

    expired
  22. US 7009044

    HCV/BVDV chimeric genomes and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 7, 2006 · Expires Mar 2, 2026

    expired
  23. US 7001614

    Liposome complexes for increased systemic delivery

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 21, 2006 · Expires Feb 16, 2026

    expired
  24. US 7001600

    Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Feb 21, 2006 · Expires Feb 16, 2026

    expired